2004
DOI: 10.1182/blood-2002-12-3861
|View full text |Cite
|
Sign up to set email alerts
|

IL-7–dependent human leukemia T-cell line as a valuable tool for drug discovery in T-ALL

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
50
2

Year Published

2008
2008
2020
2020

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 42 publications
(57 citation statements)
references
References 48 publications
(60 reference statements)
5
50
2
Order By: Relevance
“…Activation of the PI3K and Erk1/2 pathways in pre-T cells in response to IL-7 has not been previously evaluated (67). We found that IL-7 activated Akt and STAT5, as well as Erk1/2, which is in line with the finding that IL-7 activates Erk1/2 in an IL-7-dependent immature T cell line, TAIL-7 (68,69). Unlike STAT5 and Akt activation, both of which showed substantial increases upon IL-7 treatment, IL-7 activated Erk1/2 only in a small percentage of cells (ϳ8%), which correlated well with the marginal increase in CD25 expression in response to IL-7.…”
Section: Discussionsupporting
confidence: 81%
“…Activation of the PI3K and Erk1/2 pathways in pre-T cells in response to IL-7 has not been previously evaluated (67). We found that IL-7 activated Akt and STAT5, as well as Erk1/2, which is in line with the finding that IL-7 activates Erk1/2 in an IL-7-dependent immature T cell line, TAIL-7 (68,69). Unlike STAT5 and Akt activation, both of which showed substantial increases upon IL-7 treatment, IL-7 activated Erk1/2 only in a small percentage of cells (ϳ8%), which correlated well with the marginal increase in CD25 expression in response to IL-7.…”
Section: Discussionsupporting
confidence: 81%
“…Most prior studies have focused on signaling via IL-7 (Dibirdik et al, 1991;Barata et al, 2004aBarata et al, ,b,c, 2005González-Garcia et al, 2009;Shochat et al, 2011;Silva et al, 2011) or mutational activation of intermediates in the PI3K-Akt pathway Gutierrez et al, 2009). The importance of PI3K-Akt activation in T-ALL is underscored by multiple studies showing that PI3K-Akt/mTOR inhibitors block growth/survival of T-ALL cells (Avellino et al, 2005;Wei et al, 2006;Palomero et al, 2007;Chiarini et al, 2009;Cullion et al, 2009).…”
Section: Methodsmentioning
confidence: 99%
“…Although previous works have focused on the role of IL-7 signaling in T-ALL, including effects on downstream PI3K-Akt activation (Dibirdik et al, 1991;Barata et al, 2004aBarata et al, ,b,c, 2005González-Garcia et al, 2009;Shochat et al, 2011;Silva et al, 2011), we considered that insulin-like growth factor (IGF)-1 receptor (IGF1R) may also play an important role. IGFs and their receptors regulate normal cell growth and contribute to transformation and growth of malignant cells in many contexts (Pollak et al, 2004).…”
Section: Pharmacologic Inhibition Of Igf1r Compromises T-all Cell Growthmentioning
confidence: 99%
“…TAIL7 cells share significant similarities with primary T-ALL samples. 18 In vitro culture IL-7-deprived TAIL7 cells or primary T-ALL cells were cultured as 2 Â 10treated for 30 min with H 2 O 2 and glucose oxidase to obtain steady-state levels of H 2 O 2 , as described. 19 Cells were then washed with phosphate-buffered saline and cultured under normal conditions for 48 h. Human peripheral blood mononuclear cells were cultured for 2 days with phorbol 12-myristate 13-acetate (10 ng/ml, Sigma-Aldrich) and ionomycin (1 mg/ml, Sigma-Aldrich), then washed and grown for at least 24 h in medium supplemented with 10 U/ml rhIL-2 (Roche Molecular Biochemicals, Mannheim, Germany).…”
Section: Cellsmentioning
confidence: 99%